Financials
- Market Capitalization 376.13 M
- Employee 55
- Founded 2012
- CEO N/A
- Website www.ateapharma.com
- Headquarter Massachusetts, United States
- FIGI BBG00TZNCJ75
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-1.84
ratio cours/chiffre d'affaires
—
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 3133 | ENTA Enanta Pharmaceuticals, Inc. - Common Stock | 13.11 USD | -3.89% | -6.76% | +14.60% | +98.94% | 381.22 M USD | ||
| 3138 | XFOR X4 Pharmaceuticals, Inc. - Common Stock | 4.02 USD | -0.74% | +3.88% | -1.95% | +35.35% | 379.17 M USD | ||
| 3174 | LXEO Lexeo Therapeutics, Inc. - Common Stock | 4.62 USD | -0.65% | -3.95% | -2.12% | +11.06% | 362.77 M USD | ||
| 3196 | VNDA Vanda Pharmaceuticals Inc. - Common Stock | 5.85 USD | -2.50% | -8.59% | -0.51% | +5.79% | 351.79 M USD |